R21082463 |
ASP4132 |
ASP4132 is an orally active, potent AMPK activator with an EC50 of 18 nM. ASP41
|
R21082464 |
MYCI975 |
MYCi975 (NUCC-0200975) is an orally active MYC inhibitor that disrupts the MYC/M
|
R21082465 |
MYCI361 |
MYCi361 (NUCC-0196361) is a MYC inhibitor with a Kd of 3.2 μM. MYCi361 (NUCC-01
|
R21082466 |
GSK2837808A |
GSK2837808A is A potent and selective lactate dehydrogenase A (LDHA) inhibitor w
|
R21082467 |
ML-9 hydrochloride |
Ml-9 is a potent and selective inhibitor of Akt kinase that inhibits myosin ligh
|
R21082468 |
PRI-724 |
PRI-724, an isomer or enantiomer of ICG-001, is a potent, specific inhibitor of
|
R21082469 |
Picropodophyllotoxin(PPP) |
Picropodophyllin (AXL1717) is a selective insulin-like growth factor-1 receptor
|
R21082470 |
GCN2iB |
GCN2iB is an ATP-competitive inhibitor of stress response kinase (GCN2), a serin
|
R21082471 |
Fatostatin HBr |
Fatostatin hydrobromide (125B11 hydrobromide) is a specific inhibitor of SREBP a
|
R21082472 |
MYF-01-37 |
MYF-01-37 is a novel covalent inhibitor of TEAD targeting Cys380 when incubated
|
R21082473 |
Valemetostat |
Valemetostat is an antitumor agent.
|
R21082474 |
HS-243 |
HS-243 is an inhibitor of transforming growth factor-beta kinase. HS-243 can be
|
R21082475 |
LY-3381916 |
Ly-3381916 is an effective, selective, transbbB IDO1 inhibitor that can bind to
|
R21082476 |
CU-CPT-9a |
CU-CPT9b is an antagonist of toll-like receptor 8 (TLR8; Kd = 21 nM). It inhibit
|
R21082477 |
Pitstop 2 |
Pitstop 2 is a small molecule inhibitor of clathrin terminal domain and inhibits
|
R21082478 |
TAS4464 |
TAS4464 is a highly selective inhibitor of NEDD8 activase (NAE) with an IC50 val
|
R21082479 |
BTK inhibitor 17 |
BTK inhibitor 17 is a potent oral active irreversible BTK inhibitor with IC50 of
|
R21082480 |
A922500 |
A 922500 is an effective, selective and orally available dgat-1 inhibitor with a
|
R21082481 |
BI-3812 |
Bi-3812 is a highly effective inhibitor of BCL6, which can inhibit the BTB domai
|
R21082482 |
EN4 |
EN4 MYC inhibitor is a covalent ligand that targets cysteine 171 (C171) of MYC.
|
R21082483 |
pamiparib |
Pamiparib is a PARP inhibitor that can be used to treat a variety of cancers, in
|
R21082484 |
U0126 |
U0126 is a potent, non-ATP-competitive, selective inhibitor of MEK1 and MEK2 wit
|
R21082485 |
TPX-0022 |
Csf1r-in-2 (Compound 5) is an oral effective inhibitor of SRC, MET and C-FMS, wi
|
R21082486 |
AGI1067;Succinobucol |
Succinobucol is a phenolic antioxidant that has anti-inflammatory and anti-plate
|
R21082487 |
CBP-IN-1 |
Cbp-in-1 is a highly effective p300/CBP bromine domain inhibitor.
|